Kolexia
Gisbert Sophie Gynécologie
Gisbert Sophie
Gynécologie
Centre Hospitalier Alpes Léman
Contamine-sur-Arve, France
17 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Urticaire chronique Urticaire Cold Urticaria Maladies auto-immunes Lupus érythémateux disséminé Lupus érythémateux cutané Maladie chronique Hémorragie Hémorragie de la délivrance

Collaborateurs

Voir plus
Bertholdt Charline
Bertholdt Charline
Maternité de Nancy, Nancy, France
Morel Olivier
Morel Olivier
Maternité de Nancy, Nancy, France
Pouypoudat Laura
Pouypoudat Laura
Centre Hospitalier de Grasse, Grasse, France
Callec Ronan
Callec Ronan
Cabinet libéral, Écully, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2022
GSK
1 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double-blind placebo-controlled study.
British journal of clinical pharmacology   18 juin 2021
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects: A Double-blind (Sponsor Unblinded) Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of Repeat Dosing of GSK2646264 in Cutaneous Lupus Erythematosus Patients
Essai Clinique (GSK)   11 mars 2021
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Experimental dermatology   17 décembre 2020
Republication de : Risque périnéal et mesures de protection obstétricale : enquête auprès des professionnels de la naissance
La Revue Sage-Femme   01 novembre 2019
Perineal risk and obstetrical protection: A survey with birth professionals.
Gynecologie, obstetrique, fertilite & senologie   16 avril 2019
Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264: A Randomised Double Blind (Sponsor Unblinded), Single and Repeat Ascending Dose First Time in Human Study in Healthy Subjects, Cold Urticaria and Chronic Spontaneous Urticaria Subjects to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
Essai Clinique (GSK)   27 mars 2019
Maternal outcomes in case of cesarean before 32 weeks of gestation: A retrospective observational study
European journal of obstetrics, gynecology, and reproductive biology   01 mars 2019
Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.
British journal of clinical pharmacology   03 décembre 2018
Maternal outcomes in case of cesarean before 32weeks of gestation: A retrospective observational study.
Gynecologie, obstetrique, fertilite & senologie   31 août 2018
Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers: A Randomised, Double-Blind (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Single Ascending Doses of a Fully Humanized Anti-IL-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
Essai Clinique (GSK)   05 mai 2017